Opthea Limited: Major Catalyst In Early 2025 For Complementary Eye Disease Candidate
Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...
The timeless English landscape under threat from Net Zero
The view from the top of the tower of St James’s church in Louth, on the eastern edge of the Lincolnshire Wolds, is breathtaking. Above soars the highest spire on any medieval parish church in England ...
Revolve Strengthens Executive Management Team
VANCOUVER, BC / ACCESSWIRE / November 6, 2024 / (TSXV:REVV)(OTCQB:REVVF) ("Revolve" or the "Company"), a North American owner, operator and developer of renewable energy projects, announces ...
Sono Group N.V.’s CEO Shareholder Update
The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono” or the “Company”, parent company to Sono Motors GmbH or “Sono Motors”) today issued an update to the ...